Cargando…
Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
Compelling pieces of evidence derived from both clinical and experimental research has demonstrated the crucial role of the receptor for advanced-glycation end-products (RAGE) in orchestrating a plethora of proinflammatory cellular responses leading to many of the complications and end-organ damages...
Autores principales: | Rojas, Armando, Lindner, Cristian, Gonzàlez, Ileana, Morales, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107984/ https://www.ncbi.nlm.nih.gov/pubmed/33995847 http://dx.doi.org/10.4239/wjd.v12.i5.590 |
Ejemplares similares
-
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer
por: Rojas, Armando, et al.
Publicado: (2023) -
Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider
por: Rojas, Armando, et al.
Publicado: (2022) -
Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?
por: Rojas, Armando, et al.
Publicado: (2021) -
Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy
por: Shi, Liu, et al.
Publicado: (2021) -
Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)